Bank of Montreal’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-14,800
Closed -$3.45M 4851
2019
Q3
$3.45M Buy
+14,800
New +$3.45M ﹤0.01% 1363
2015
Q4
Sell
-20,000
Closed -$5.84M 4222
2015
Q3
$5.84M Buy
+20,000
New +$6.6M 0.01% 921

Other funds holding BIIB

Bank of Montreal's BIIB Position: Q2 2026 in Review

Bank of Montreal increased its Biogen (BIIB) stake by 34% in Q2 2026, buying an estimated $6.04M and bringing the position to 124,267 shares worth $26.8M. The position accounts for 0.01% of the portfolio, ranked #800.

Bank of Montreal first reported a position in BIIB in Q2 2013 and has held it in 53 quarters since. The position peaked at $123M in Q4 2018. 746 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Bank of Montreal held 124,267 shares of Biogen worth $26.8M as of Q2 2026.
  • Bank of Montreal bought 31,558 Biogen shares in Q2 2026, an estimated $6.04M.
  • Biogen made up 0.01% of Bank of Montreal's portfolio in Q2 2026, its #800 holding.
  • Bank of Montreal first reported a position in Biogen in Q2 2013 and has held it in 53 quarters since.
  • Bank of Montreal's Biogen position peaked at $123M in Q4 2018.
  • 746 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.